Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Vomiting
ADR ID BADD_A04623
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.07      Nausea and vomiting symptoms
07.01.07.003      Vomiting
Description A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth. [CTCAE] The forcible expulsion of the contents of the STOMACH through the MOUTH. [MeSH]
MedDRA Code 10047700
MeSH ID D014839
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bilious vomiting | Emesis | Habit vomiting | Hyperemesis | Nausea and vomiting | Nausea vomiting and diarrhea | Nausea vomiting and diarrhoea | Nausea with vomiting | Persistent vomiting | Vomited | Vomiting | Vomiting alone | Vomiting NOS | Vomiting reflex | Vomiting aggravated | Vomiting of medication | Tablet in vomitus | Vomiting post chemotherapy | Vomiting post radiotherapy | Blennemesis | Postprandial emesis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00567Dabrafenib mesylate--
BADD_D00568Dacarbazine0.000224%
BADD_D00571Dactinomycin0.000168%
BADD_D00572Dalbavancin--
BADD_D00573Dalbavancin hydrochloride--
BADD_D00574Dalfampridine--
BADD_D00576Danazol0.002361%
BADD_D00577Dantrolene sodium--
BADD_D00578Dapagliflozin--
BADD_D00580Dapsone0.003007%
BADD_D00581Daptomycin--
BADD_D00582Daratumumab--
BADD_D00584Darifenacin--
BADD_D00585Darifenacin hydrobromide--
BADD_D00586Darunavir--
BADD_D00587Darunavir ethanolate--
BADD_D00589Dasatinib--
BADD_D00590Daunorubicin--
BADD_D00591Daunorubicin citrate--
BADD_D00592Daunorubicin hydrochloride--
BADD_D00593Decitabine--
BADD_D00594Deferasirox0.191691%
BADD_D00595Deferiprone0.015117%
BADD_D00596Deferoxamine--
BADD_D00597Deferoxamine mesylate--
BADD_D00598Defibrotide sodium--
BADD_D00599Degarelix--
BADD_D00602Delamanid--
BADD_D00603Delavirdine--
BADD_D00604Delavirdine mesylate--
The 14th Page    First    Pre   14 15 16 17 18    Next   Last    Total 62 Pages
ADReCS-Target
ADR Term Drug Name Target